Lisa den Hollander
Promovendus / intern
- Naam
- L.S. den Hollander MSc
- Telefoon
- +31 71 527 2727
- l.s.den.hollander@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0002-8954-3460
For more information look at the English web site
Promovendus / intern
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Medicinal Chemistry
- Hollander L.S. den, IJzerman A.P. & Heitman L.H. (2024), Pharmacological characterization of allosteric modulators: a case for chemokine receptors, Medicinal Research Reviews : 1-16.
- Hollander L.S. den (25 september 2024), From every angle: novel insights into CC chemokine receptor 2 pharmacology (Dissertatie. Leiden Academic Centre for Drug Research (LACDR), Faculty of Science, Leiden University). Promotor(en): Heitman A.P. & Heitman L.H.
- den Hollander Lisa S. Zweemer Annelien J.M. Béquignon Olivier J.M. Hammerl Dora M. Bleijs Bente T.M. Veenhuizen Margo Lantsheer Wernard J.F. Chau Bobby van Westen Gerard J.P. IJzerman Adriaan P. Heitman Laura H. (2024), CC chemokine receptor 2 is allosterically modulated by sodium ions and amiloride derivatives through a distinct sodium ion binding site, Biochemical Pharmacology 229: 116464.
- Hollander L.S. den, Béquignon O.J.M., Wang X., Wezel K. van, Broekhuis J., Gorostiola González M., Visser K.E. de, IJzerman A.P., Westen G.J.P. van & Heitman L.H. (2022), Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism, Biochemical Pharmacology 208: 115399.
- Ortiz Zacarías N.V., Veldhoven J.P.D. van, Hollander L.S. den, Dogan B., Openy J., Hsiao Y.Y., Lenselink E.B., Heitman L.H. & IJzerman A.P. (2019), Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5, Journal of Medicinal Chemistry 62(24): 11035-11053.